Experience of mismatch repair/microsatellite instability (MMR/MSI) testing among patients with advanced/metastatic colorectal cancer in the US

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28(2):264–271.
   PubMed Web of Science ®Google Scholar
• Chang L, Chang M, Chang HM, et al. Expending role of microsatellite instability in diagnosis and treatment of colorectal cancers. J Gastrointest Cancer. 2017;48(4):305–313.
   PubMed Web of Science ®Google Scholar
• Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69–77.
   PubMed Web of Science ®Google Scholar
• Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100(2):266–273.
   PubMed Web of Science ®Google Scholar
• Shia J, Ellis NA, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol. 2003;27(11):1407–1417.
   PubMed Web of Science ®Google Scholar
• Smyrk TC, Watson P, Kaul K, et al. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91(12):2417–2422.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Foster NR, Thibodeau SN, et al. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011;103(11):863–875.
   PubMedGoogle Scholar
• Fujiyoshi K, Yamamoto G, Takenoya T, et al. Metastatic pattern of stage IV colorectal cancer with high-frequency microsatellite instability as a prognostic factor. Anticancer Res. 2017;37(1):239–247.
   PubMed Web of Science ®Google Scholar
• Price TJ, Karapetis CS, Joanne Y, et al. Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability. J Clin Oncol. 2018;36(4_suppl):759–759.
   Google Scholar
• Shulman K, Barnett-Griness O, Friedman V, et al. Outcomes of chemotherapy for microsatellite instable–high metastatic colorectal cancers. JCO Precision Oncology. 2018;2:1–10.
   PubMed Web of Science ®Google Scholar
• Jin Z, Sanhueza CT, Johnson B, et al. Outcome of mismatch repair-deficient metastatic colorectal cancer: the Mayo clinic experience. Oncologist. 2018;23(9):1083–1091.
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–257.
   PubMed Web of Science ®Google Scholar
• Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219–3226.
   PubMed Web of Science ®Google Scholar
• Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 1998;95(12):6870–6875.
   PubMed Web of Science ®Google Scholar
• Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354(26):2751–2763.
   PubMed Web of Science ®Google Scholar
• Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83(2):259–266.
   PubMed Web of Science ®Google Scholar
• Referenced with the permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon Cancer V.4.2019.® National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed December 3, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibilities for their application or use in any way.
   Google Scholar
• Referenced with the permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Rectal Cancer V.3.2019. ® National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed December 3, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibilities for their application or use in any way.
   Google Scholar
• Manne SL, Chung DC, Weinberg DS, et al. Knowledge and attitudes about Microsatellite Instability Testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2110–2117.
   PubMed Web of Science ®Google Scholar
• Katz LH, Burton-Chase AM, Advani S, et al. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Clin Genet. 2016;89(3):392–398.
   PubMed Web of Science ®Google Scholar
• US Census Bureu; 2018. Available from: https://www.census.gov/.
   Google Scholar
• Kolligs FT. Diagnostics and epidemiology of colorectal cancer. Visc Med. 2016;32(3):158–164.
   PubMed Web of Science ®Google Scholar
• Hall MJ, Manne SL, Winkel G, et al. Effects of a decision support intervention on decisional conflict associated with Microsatellite Instability Testing. Cancer Epidemiol Biomarkers Prev. 2011;20(2):249–254.
   PubMed Web of Science ®Google Scholar
• Shaikh T, Handorf EA, Meyer JE, et al. Mismatch repair deficiency testing in patients with colorectal cancer and nonadherence to testing guidelines in young adults. JAMA Oncol. 2018;4(2):e173580.
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Adams R, Tabernero J, et al. Awareness, understanding, and adoption of precision medicine to deliver personalized treatment for patients with cancer: a multinational survey comparison of physicians and patients. Oncologist. 2016;21(3):292–300.
   PubMed Web of Science ®Google Scholar
• Bleiker EM, Esplen MJ, Meiser B, et al. 100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer. 2013;12(2):325–339.
   PubMed Web of Science ®Google Scholar
• Genetic Testing Coverage & Reimbursement: ASCO; [cited 2019 April 12]. Available from: https://www.asco.org/practice-guidelines/cancer-care-initiatives/genetics-toolkit/genetic-testing-coverage-reimbursement.
   Google Scholar
• Eriksson J, Amonkar M, Al-Jassar G, et al. Mismatch repair/microsatellite instability testing practices among US physicians treating patients with advanced/metastatic colorectal cancer. J Clin Med. 2019;8(4):558.
   Web of Science ®Google Scholar